Loading...
AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors
AT-1001 [N-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1] nonan-3-amine] is a high-affinity and highly selective ligand at α3β4 nicotinic cholinergic receptors (nAChRs) that was reported to decrease nicotine self-administration in rats. It was initially reported to be an antagonist at rat α3β4 nAChRs...
Na minha lista:
Udgivet i: | Mol Pharmacol |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4576681/ https://ncbi.nlm.nih.gov/pubmed/26162864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.099978 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|